The DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index.
Nanomedicine in pulmonary delivery
Open accessAbstract
Nanomedicine in pulmonary delivery Heidi M Mansour, Yun-Seok Rhee, Xiao WuUniversity of Kentucky, College of Pharmacy, Division of Pharmaceutical Sciences-Drug Development Division, Lexington, KY, USAAbstract: The lung is an attractive target for drug delivery due to noninvasive administration via inhalation aerosols, avoidance of first-pass metabolism, direct delivery to the site of action for the treatment of respiratory diseases, and the availability of a huge surface area for local drug action and systemic absorption of drug. Colloidal carriers (ie, nanocarrier systems) in pulmonary drug delivery offer many advantages such as the potential to achieve relatively uniform distribution of drug dose among the alveoli, achievement of improved solubility of the drug from its own aqueous solubility, a sustained drug release which consequently reduces dosing frequency, improves patient compliance, decreases incidence of side effects, and the potential of drug internalization by cells. This review focuses on the current status and explores the potential of colloidal carriers (ie, nanocarrier systems) in pulmonary drug delivery with special attention to their pharmaceutical aspects. Manufacturing processes, in vitro/in vivo evaluation methods, and regulatory/toxicity issues of nanomedicines in pulmonary delivery are also discussed.Keywords: pulmonary delivery, colloidal carriers, nanocarrier systems, liposome, polymeric nanoparticle, solid lipid nanoparticle, submicron emulsion, dendrimer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
Oberdörster, G., Oberdörster, E., & Oberdörster, J. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7339 · Cited by 7,891
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
The effect of particle design on cellular internalization pathways
Gratton, S. E. A., Ropp, P. A., Pohlhaus, P. D., Luft, J. C., Madden, V. J., Napier, M. E., & DeSimone, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801763105 · Cited by 2,918
Translocation of inhaled ultrafine particles to the brain
Oberdörster, G., Sharp, Z., Atudorei, V., Elder, A., Gelein, R., Kreyling, W., & Cox, C. (2004) · Inhalation Toxicology · doi:10.1080/08958370490439597 · Cited by 2,606
Nanosuspensions in drug delivery
Rabinow, B. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1494 · Cited by 1,524
Inhaling medicines: delivering drugs to the body through the lungs
Patton, J. S., & Byron, P. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2153 · Cited by 1,331
Boas, U., & Heegaard, P. M. H. (2004) · Chemical Society Reviews · doi:10.1039/b309043b · Cited by 1,175
Noninvasive Imaging of Quantum Dots in Mice
Ballou, B., Lagerholm, B. C., Ernst, L. A., Bruchez, M. P., & Waggoner, A. S. (2004) · Bioconjugate Chemistry · doi:10.1021/bc034153y · Cited by 1,140
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.006 · Cited by 956
Cationic Polymer Based Gene Delivery Systems
De Smedt, S. C., Demeester, J., & Hennink, W. E. (2000) · Pharmaceutical Research · doi:10.1023/a:1007548826495 · Cited by 884
Oberdörster, G., Sharp, Z., Atudorei, V., Elder, A., Gelein, R., Lunts, A., Kreyling, W., & Cox, C. (2002) · Journal of Toxicology and Environmental Health, Part A · doi:10.1080/00984100290071658 · Cited by 846
Solid lipid nanoparticles as a drug delivery system for peptides and proteins☆
ALMEIDA, A., & SOUTO, E. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.007 · Cited by 814
Tang, M., & Szoka, F. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300454 · Cited by 814
Kreyling, W. G., Semmler, M., Erbe, F., Mayer, P., Takenaka, S., Schulz, H., Oberdörster, G., & Ziesenis, A. (2002) · Journal of Toxicology and Environmental Health, Part A · doi:10.1080/00984100290071649 · Cited by 790
Progress in developing cationic vectors for non-viral systemic gene therapy against cancer
Morille, M., Passirani, C., Vonarbourg, A., Clavreul, A., & Benoit, J.-P. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.04.036 · Cited by 769
Foster, K. A., Oster, C. G., Mayer, M. M., Avery, M. L., & Audus, K. L. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4172 · Cited by 713
Different behavior of branched and linear polyethylenimine for gene deliveryin vitro andin vivo
Wightman, L., Kircheis, R., R�ssler, V., Carotta, S., Ruzicka, R., Kursa, M., & Wagner, E. (2001) · The Journal of Gene Medicine · doi:10.1002/jgm.187 · Cited by 697
Inhaled nanoparticles—A current review
Yang, W., Peters, J. I., & Williams, R. O. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.02.011 · Cited by 666
Particle Engineering for Pulmonary Drug Delivery
Chow, A. H. L., Tong, H. H. Y., Chattopadhyay, P., & Shekunov, B. Y. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9174-3 · Cited by 645
Nanoparticles for drug delivery to the lungs
Sung, J. C., Pulliam, B. L., & Edwards, D. A. (2007) · Trends in Biotechnology · doi:10.1016/j.tibtech.2007.09.005 · Cited by 643
Potential of solid lipid nanoparticles in brain targeting.
Kaur, I. P., Bhandari, R., Bhandari, S., & Kakkar, V. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.018 · Cited by 615
RNA Interference in Vitro and in Vivo Using a Novel Chitosan/siRNA Nanoparticle System
Howard, K. A., Rahbek, U. L., Liu, X., Damgaard, C. K., Glud, S. Z., Andersen, M. Ø., Hovgaard, M. B., Schmitz, A., Nyengaard, J. R., Besenbacher, F., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.04.010 · Cited by 585
Schwarz, C., Mehnert, W., Lucks, J. S., & Müller, R. H. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90047-7 · Cited by 574
Khanna, C., Anderson, P. M., Hasz, D. E., Katsanis, E., Neville, M., & Klausner, J. S. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970401)79:7 · Cited by 561
Relationship between Particle Mass and Mobility for Diesel Exhaust Particles
Park, K., Cao, F., Kittelson, D. B., & McMurry, P. H. (2002) · Environmental Science & Technology · doi:10.1021/es025960v · Cited by 545
Polyethylenimine-mediated gene delivery: a mechanistic study
Kichler, A., Leborgne, C., Coeytaux, E., & Danos, O. (2001) · The Journal of Gene Medicine · doi:10.1002/jgm.173 · Cited by 517
Toxicology of ultrafine particles:in vivo studies
Oberdürster, G. (2000) · Philosophical Transactions of the Royal Society of London. Series A: Mathematical, Physical and Engineering Sciences · doi:10.1098/rsta.2000.0680 · Cited by 511
Polymeric nanomedicine for cancer therapy
Park, J. H., Lee, S., Kim, J.-H., Park, K., Kim, K., & Kwon, I. C. (2008) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.09.003 · Cited by 506
Microencapsulated chitosan nanoparticles for lung protein delivery
Grenha, A., Seijo, B., & Remuñán-López, C. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.04.009 · Cited by 469
Targeted delivery of nanoparticles for the treatment of lung diseases
Azarmi, S., Roa, W. H., & Löbenberg, R. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.006 · Cited by 440
The lung as a route for systemic delivery of therapeutic proteins and peptides
Uchenna Agu, R., Ikechukwu Ugwoke, M., Armand, M., Kinget, R., & Verbeke, N. (2001) · Respiratory Research · doi:10.1186/rr58 · Cited by 411
Alton, E. W. F. W., Middleton, P. G., Caplen, N. J., Smith, S. N., Steel, D. M., Munkonge, F. M., Jeffery, P. K., Geddes, D. M., Hart, S. L., Williamson, R., et al. (1993) · Nature Genetics · doi:10.1038/ng1093-135 · Cited by 402
Yamamoto, H., Kuno, Y., Sugimoto, S., Takeuchi, H., & Kawashima, Y. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.10.010 · Cited by 389
Pandey, R. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg477 · Cited by 388
Köping-Höggård, M., Vårum, K., Issa, M., Danielsen, S., Christensen, B., Stokke, B., & Artursson, P. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302312 · Cited by 385
Side‐effects of a systemic injection of linear polyethylenimine–DNA complexes
Chollet, P., Favrot, M. C., Hurbin, A., & Coll, J. (2002) · The Journal of Gene Medicine · doi:10.1002/jgm.237 · Cited by 373
Analysis of Amorphous and Nanocrystalline Solids from Their X-Ray Diffraction Patterns
Bates, S., Zografi, G., Engers, D., Morris, K., Crowley, K., & Newman, A. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9086-2 · Cited by 372
Protein Inhalation Powders: Spray Drying vs Spray Freeze Drying
Maa, Y.-F., Nguyen, P.-A., Sweeney, T., Shire, S. J., & Hsu, C. C. (1999) · Pharmaceutical Research · doi:10.1023/a:1018828425184 · Cited by 356
Lin, C.-C., Chen, S.-J., Huang, K.-L., Hwang, W.-I., Chang-Chien, G.-P., & Lin, W.-Y. (2005) · Environmental Science & Technology · doi:10.1021/es048182a · Cited by 350
Particle formation with supercritical fluids—a review
Tom, J. W., & Debenedetti, P. G. (1991) · Journal of Aerosol Science · doi:10.1016/0021-8502(91)90013-8 · Cited by 342
Microspheres and nanoparticles used in ocular delivery systems
Zimmer, A., & Kreuter, J. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00017-2 · Cited by 336
Sakagami, M. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.012 · Cited by 331
Pandey, R., & Khuller, G. K. (2005) · Tuberculosis · doi:10.1016/j.tube.2004.11.003 · Cited by 318
Assessment of disorder in crystalline solids
Saleki-Gerhardt, A., Ahlneck, C., & Zografi, G. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90219-4 · Cited by 315
Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis
Zahoor, A., Sharma, S., & Khuller, G. K. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.07.012 · Cited by 314
Human respiratory epithelial cell culture for drug delivery applications
Forbes, B., & Ehrhardt, C. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.02.010 · Cited by 306
Nanoparticle formulations in pulmonary drug delivery
Bailey, M. M., & Berkland, C. J. (2009) · Medicinal Research Reviews · doi:10.1002/med.20140 · Cited by 302
Acute pulmonary effects of ultrafine particles in rats and mice.
Oberdörster, G., Finkelstein, J. N., Johnston, C. J., Gelein, R. M., Cox, C., Baggs, R. B., & Elder, A. C. P. (2000) · PubMed · Cited by 287
Sham, J. O.-H., Zhang, Y., Finlay, W. H., Roa, W. H., & Löbenberg, R. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.041 · Cited by 284
Aerosol gene delivery in vivo.
Stribling, R., Brunette, E., Liggitt, D., Gaensler, K., & Debs, R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.23.11277 · Cited by 270
Fundamentals of pulmonary drug delivery
GRONEBERG, D. A., WITT, C., WAGNER, U., CHUNG, K. F., & FISCHER, A. (2003) · Respiratory Medicine · doi:10.1053/rmed.2002.1457 · Cited by 270
Gratton, S. E. A., Pohlhaus, P. D., Lee, J., Guo, J., Cho, M. J., & DeSimone, J. M. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.027 · Cited by 266
Cytotoxicity of Solid Lipid Nanoparticles as a Function of the Lipid Matrix and the Surfactant
Müller, R. H., Rühl, D., Runge, S., Schulze-Forster, K., & Mehnert, W. (1997) · Pharmaceutical Research · doi:10.1023/a:1012043315093 · Cited by 265
Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages
Vyas, S. P., Kannan, M. E., Jain, S., Mishra, V, & Singh, P. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.08.017 · Cited by 262
Characterization of the Calu-3 cell line as a tool to screen pulmonary drug delivery
Foster, K. A., Avery, M. L., Yazdanian, M., & Audus, K. L. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00452-x · Cited by 256
Solid lipid nanoparticles for pulmonary delivery of insulin
Liu, J., Gong, T., Fu, H., Wang, C., Wang, X., Chen, Q., Zhang, Q., He, Q., & Zhang, Z. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.01.008 · Cited by 248
Chono, S., Li, S.-D., Conwell, C. C., & Huang, L. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.07.006 · Cited by 238
CHATTOPADHYAY, P., SHEKUNOV, B., YIM, D., CIPOLLA, D., BOYD, B., & FARR, S. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.010 · Cited by 227
Delivery Vehicles for Small Interfering RNA In Vivo
de Fougerolles, A. R. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.928 · Cited by 226
Ståhl, K., Claesson, M., Lilliehorn, P., Lindén, H., & Bäckström, K. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00945-0 · Cited by 214
Lymphatic Uptake of Pulmonary Delivered Radiolabelled Solid Lipid Nanoparticles
Videira, M. A., Botelho, M. F., Santos, A. C., Gouveia, L. F., Pedroso de Lima, J. J., & Almeida, A. J. (2002) · Journal of Drug Targeting · doi:10.1080/1061186021000054933 · Cited by 213
Kaul, G., & Amiji, M. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-4590-3 · Cited by 204
Nanoparticle-based dmg delivery systems
Kreuter, J. (1991) · Journal of Controlled Release · doi:10.1016/0168-3659(91)90040-k · Cited by 203
A Review of Nanocarrier-Based CNS Delivery Systems
Tiwari, S., & Amiji, M. (2006) · Current Drug Delivery · doi:10.2174/156720106776359230 · Cited by 200
Biopharmaceutical Powders Particle Formation and Formulation Considerations
Maa, Y.-F., & Prestrelski, S. (2000) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201003378898 · Cited by 200
Bivas-Benita, M., van Meijgaarden, K. E., Franken, K. L. M. C., Junginger, H. E., Borchard, G., Ottenhoff, T. H. M., & Geluk, A. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.09.044 · Cited by 195
In vivo gene delivery to the lung using polyethylenimine and fractured polyamidoamine dendrimers
Rudolph, C., Lausier, J., Naundorf, S., M�ller, R. H., & Rosenecker, J. (2000) · The Journal of Gene Medicine · doi:10.1002/1521-2254(200007/08)2:4<269::aid-jgm112>3.0.co;2-f · Cited by 194
Solid-state analysis of the active pharmaceutical ingredient in drug products
Newman, A. W., & Byrn, S. R. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02832-0 · Cited by 184
Verschraegen, C. F., Gilbert, B. E., Loyer, E., Huaringa, A., Walsh, G., Newman, R. A., & Knight, V. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0929-3 · Cited by 183
Ohashi, K., Kabasawa, T., Ozeki, T., & Okada, H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.11.027 · Cited by 178
Alternative sugars as potential carriers for dry powder inhalations
Steckel, H., & Bolzen, N. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.10.039 · Cited by 176
Solid lipid nanoparticles (SLN) for controlled drug delivery
Müller, R. H., Freitas, C., zur Mühlen, A., & Mehnert, W. (1996) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(97)86243-4 · Cited by 174
Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles
AZARMI, S., TAO, X., CHEN, H., WANG, Z., FINLAY, W., LOBENBERG, R., & ROA, W. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.03.052 · Cited by 169
Transfection of airway epithelium by stable PEGylated poly-l-lysine DNA nanoparticles in vivo
Ziady, A.-G., Gedeon, C. R., Miller, T., Quan, W., Payne, J. M., Hyatt, S. L., Fink, T. L., Muhammad, O., Oette, S., Kowalczyk, T., et al. (2003) · Molecular Therapy · doi:10.1016/j.ymthe.2003.07.007 · Cited by 165
Pulmonary delivery of insulin by liposomal carriers
Huang, Y.-Y., & Wang, C.-H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.03.014 · Cited by 164
Zhang, Q., Shen, Z., & Nagai, T. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00614-7 · Cited by 159
Dendrimers as a Carrier for Pulmonary Delivery of Enoxaparin, a Low-Molecular Weight Heparin
Bai, S., Thomas, C., & Ahsan, F. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20849 · Cited by 158
Wijagkanalan, W., Kawakami, S., Takenaga, M., Igarashi, R., Yamashita, F., & Hashida, M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.10.011 · Cited by 158
Chono, S., Tanino, T., Seki, T., & Morimoto, K. (2006) · Journal of drug targeting · doi:10.1080/10611860600834375 · Cited by 157
Liposome delivery of ciprofloxacin against intracellular Francisella tularensis infection
Wong, J. P., Yang, H., Blasetti, K. L., Schnell, G., Conley, J., & Schofield, L. N. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00358-4 · Cited by 153
Improved Lung Delivery from a Passive Dry Powder Inhaler Using an Engineered PulmoSphere® Powder
Duddu, S. P., Sisk, S. A., Walter, Y. H., Tarara, T. E., Trimble, K. R., Clark, A. R., Eldon, M. A., Elton, R. C., Pickford, M., Hirst, P. H., et al. (2002) · Pharmaceutical Research · doi:10.1023/a:1015322616613 · Cited by 150
Esmaeili, F., Hosseini-Nasr, M., Rad‐Malekshahi, M., Samadi, N., Atyabi, F., & Dinarvand, R. (2007) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2007.03.003 · Cited by 150
Carrier-based strategies for targeting protein and peptide drugs to the lungs
Cryan, S. (2005) · The AAPS Journal · doi:10.1208/aapsj070104 · Cited by 149
Cell Culture Models of the Respiratory Tract Relevant to Pulmonary Drug Delivery
Steimer, A., Haltner, E., & Lehr, C. (2005) · Journal of Aerosol Medicine · doi:10.1089/jam.2005.18.137 · Cited by 149
Drug Encapsulation Using Supercritical Fluid Extraction of Emulsions
Chattopadhyay, P., Huff, R., & Shekunov, B. Y. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20555 · Cited by 147
Pulmonary Tissue Access of Ultrafine Particles
Ferin, J., Oberdörster, G., Soderholm, S. C., et al. (1991) · Journal of Aerosol Medicine · doi:10.1089/jam.1991.4.57 · Cited by 140
Kimura, S., Egashira, K., Chen, L., Nakano, K., Iwata, E., Miyagawa, M., Tsujimoto, H., Hara, K., Morishita, R., Sueishi, K., et al. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.121418 · Cited by 140
Rogers, T. L., Johnston, K. P., & Williams, R. O. (2001) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-100108363 · Cited by 138
Oberdörster, G., Ferin, J., & Morrow, P. E. (1992) · Experimental Lung Research · doi:10.3109/01902149209020653 · Cited by 125
Inhibition of Allergic Inflammation in the Airways Using Aerosolized Antisense to Syk Kinase
Stenton, G. R., Ulanova, M., Déry, R. E., Merani, S., Kim, M.-K., Gilchrist, M., Puttagunta, L., Musat‐Marcu, S., James, D., Schreiber, A. D., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.2.1028 · Cited by 124
Physicochemical stability of total nutrient admixtures
Driscoll, D. F., Bhargava, H. N., Li, L., Zaim, R. H., Babayan, V. K., & Bistrian, B. R. (1995) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/52.6.623 · Cited by 124
Surface‐Modified LPD Nanoparticles for Tumor Targeting
Li, S., & Huang, L. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1348.001 · Cited by 123
Brzoska, M., Langer, K., Coester, C., Loitsch, S. M., Wagner, T. O. F., & von Mallinckrodt, C. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.067 · Cited by 122
Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model
Beck‐Broichsitter, M., Gauss, J., Packhaeuser, C. B., Lahnstein, K., Schmehl, T., Seeger, W., Kissel, T., & Gessler, T. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.09.017 · Cited by 122
Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery
Sweeney, L. G., Wang, Z., Löebenberg, R., Wong, J. P., Lange, C. F., & Finlay, W. H. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.09.010 · Cited by 119
The stability of liposomes to nebulisation
Taylor, K. M. G., Taylor, G., Kellaway, I. W., et al. (1990) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(90)90287-e · Cited by 119
Rudolph, C., Schillinger, U., Ortiz, A., Tabatt, K., Plank, C., Müller, R. H., & Rosenecker, J. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000041463.56768.ec · Cited by 119
Pulmonary delivery of liposomes
Schreier, H., Gonzalez‐Rothi, R. J., & Stecenko, A. A. (1993) · Journal of Controlled Release · doi:10.1016/0168-3659(93)90180-d · Cited by 118
Intravascular and Endobronchial DNA Delivery to Murine Lung Tissue Using a Novel, Nonviral Vector
Kukowska‐Latallo, J. F., Chen, C., Raczka, E., Qunintana, A., Rymaszewski, M., & Baker, J. R. (2000) · Human Gene Therapy · doi:10.1089/10430340050057468 · Cited by 116
Kato, T., Yashiro, T., Murata, Y., Herbert, D. C., Oshikawa, K., Bando, M., Ohno, S., & Sugiyama, Y. (2003) · Cell and Tissue Research · doi:10.1007/s00441-002-0647-3 · Cited by 113
Sardar, S. B., Fine, P. M., Mayo, P. R., & Sioutas, C. (2004) · Environmental Science & Technology · doi:10.1021/es049478j · Cited by 112
Yang, W. P., Tam, J. M., Miller, D. A., Zhou, J., McConville, J. T., Johnston, K. P., & Williams, R. O. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.05.003 · Cited by 112
Changsan, N., Chan, H., Separovic, F., & Srichana, T. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21441 · Cited by 109
Spray-freeze-dried dry powder inhalation of insulin-loaded liposomes for enhanced pulmonary delivery
Ruchang, B., Shao, W., Wang, Q., & Zhang, N. (2008) · Journal of drug targeting · doi:10.1080/10611860802201134 · Cited by 108
Freitas, S., Merkle, H. P., & Gander, B. A. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.11.005 · Cited by 107
Liu, F., Yang, J., Huang, L., & Liu, D. (1996) · Pharmaceutical Research · doi:10.1023/a:1016480421204 · Cited by 103
Xu, C., Jere, D., Jin, H., Chang, S.-H., Chung, Y.-S., Shin, J., Kim, J., Park, S. J., Lee, Y.-H., Chae, C., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-1022oc · Cited by 102
Labana, S., Pandey, R., Sharma, S., & Khuller, G. K. (2002) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(02)00175-9 · Cited by 101
Ko, Y. T., Kale, A. A., Hartner, W. C., Papahadjopoulos‐Sternberg, B., & Torchilin, V. P. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.09.079 · Cited by 100
Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages
Vyas, S. P., QURAISHI, S., Gupta, S., & Jaganathan, K. S. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.02.003 · Cited by 100
Gratton, S. E. A., Napier, M. E., Ropp, P. A., Tian, S., & DeSimone, J. M. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9654-8 · Cited by 100
Drug Absorption by the Respiratory Mucosa: Cell Culture Models and Particulate Drug Carriers
Ehrhardt, C., Fiegel, J., Fuchs, S., Abu‐Dahab, R., Schaefer, U. F., Hanes, J. S., & Lehr, C. (2002) · Journal of Aerosol Medicine · doi:10.1089/089426802320282257 · Cited by 99
Heydenreich, A. V. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00688-9 · Cited by 98
Chougule, M. B., Padhi, B. K., & Misra, A. R. (2007) · PubMed Central · Cited by 97
Characterization of Wintertime Reactive Oxygen Species Concentrations in Flushing, New York
Venkatachari, P., Hopke, P. K., Brune, W. H., Ren, X., Lesher, R. L., Mao, J., & Mitchell, M. A. (2007) · Aerosol Science and Technology · doi:10.1080/02786820601116004 · Cited by 97
Jin, H., Kim, T. H., Hwang, S., Chang, S.-H., Kim, H., Anderson, H. K., Lee, H.-W., Lee, K.-H., Colburn, N. H., Yang, H., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0433 · Cited by 96
Bai, S., & Ahsan, F. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9769-y · Cited by 95
Efficacy of liposomal budesonide in experimental asthma
Konduri, K. S., Nandedkar, S. D., Düzgüneş, N., Suzara, V. V., Artwohl, J. E., Bunte, R. M., & Gangadharam, P. R. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.104 · Cited by 95
Pulmonary cytokine responses associated with PEI–DNA aerosol gene therapy
Gautam, A. K., Densmore, C. L., & Waldrep, J. C. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301369 · Cited by 95
Minimal toxicity of stabilized compacted DNA nanoparticles in the murine lung
Ziady, A. G., Gedeon, C. R., Muhammad, O., Stillwell, V., Oette, S. M., Fink, T. L., Quan, W., Kowalczyk, T. H., Hyatt, S. L., Payne, J. M., et al. (2003) · Molecular Therapy · doi:10.1016/j.ymthe.2003.09.002 · Cited by 93
Issa, M. M., Köping‐Höggård, M., Tømmeraas, K., Vårum, K. M., Christensen, B. E., Strand, S. P., & Artursson, P. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.06.029 · Cited by 92
Effervescent dry powder for respiratory drug delivery
Ely, L., Roa, W., Finlay, W. H., & Löbenberg, R. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.10.021 · Cited by 87
Yi, S. W., Yune, T. Y., Kim, T. W., et al. (2000) · Pharmaceutical Research · doi:10.1023/a:1007553106681 · Cited by 87
Single dose and multiple dose studies of itraconazole nanoparticles
Vaughn, J. M., McConville, J. T., Burgess, D., Peters, J. I., Johnston, K. P., Talbert, R. L., & Williams, R. O. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.01.006 · Cited by 85
Carpenter, M., Epperly, M. W., Agarwal, A., Nie, S., Hricisak, L., Niu, Y., & Greenberger, J. S. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302468 · Cited by 84
A Methodology for Measuring Size-Dependent Chemical Composition of Ultrafine Particles
Geller, M. D., Kim, S., Misra, C., Sioutas, C., Olson, B. A., & Marple, V. A. (2002) · Aerosol Science and Technology · doi:10.1080/02786820290038447 · Cited by 84
Spray freezing into liquid nitrogen for highly stable protein nanostructured microparticles
Yu, Z., Garcia, A. S., Johnston, K. P., & Williams, R. O. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.04.018 · Cited by 79
Westesen, K. (2000) · Colloid & Polymer Science · doi:10.1007/s003969900257 · Cited by 79
Incorporation of Antibiotics in Liposomes Designed for Tuberculosis Therapy by Inhalation
Justo, O. R., & Moraes, Â. M. (2003) · Drug Delivery · doi:10.1080/713840401 · Cited by 77
Taetz, S., Nafee, N. A., Beisner, J., Piotrowska, K., Baldes, C., Mürdter, T. E., Huwer, H., Schneider, M., Schaefer, U. F., & Klotz, U. E. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.07.011 · Cited by 77
Colloidal gold particles as a new in vivo marker of early acute lung injury
Heckel, K., Kiefmann, R., Dörger, M., Stoeckelhuber, M., & Goetz, A. E. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00078.2004 · Cited by 76
Rudolph, C., Schillinger, U., Plank, C., Gessner, A., Nicklaus, P., Müller, R., & Rosenecker, J. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00334-3 · Cited by 75
Methods used to assess pulmonary deposition and absorption of drugs
Mobley, C., & Hochhaus, G. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)01691-9 · Cited by 72
Insulin Nanoparticles: A Novel Formulation Approach for Poorly Water Soluble Zn-Insulin
Merisko-Liversidge, E. M., McGurk, S. L., & Liversidge, G. G. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000041446.14569.e2 · Cited by 71
Gautam, A. K., Densmore, C. L., Melton, S., Golunski, E., & Waldrep, J. C. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700405 · Cited by 71
Densmore, C. L., Kleinerman, E. S., Gautam, A. K., Jia, S.-F., Xu, B., Worth, L. L., Waldrep, J. C., Fung, Y. K., Tang, A., & Knight, V. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700343 · Cited by 70
Powder properties and their influence on dry powder inhaler delivery of an antitubercular drug
Sethuraman, V. V., & Hickey, A. J. (2002) · AAPS PharmSciTech · doi:10.1208/pt030428 · Cited by 68
Respiratory epithelial cell culture models for evaluation of ion and drug transport
Mathias, N. R., Yamashita, F., & Lee, V. H. L. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00420-6 · Cited by 66
Tumor-targeted gene transfer with DNA polyplexes.
Ogris, M., & Wagner, E. (2002) · Somatic Cell and Molecular Genetics · doi:10.1023/a:1022988008131 · Cited by 65
Cryan, S., Devocelle, M. C., Moran, P. J., Hickey, A. J., & Kelly, J. G. (2005) · Molecular Pharmaceutics · doi:10.1021/mp050070i · Cited by 65
Targeted High Lung Concentrations of Itraconazole Using Nebulized Dispersions in a Murine Model
McConville, J. T., Overhoff, K. A., Sinswat, P., Vaughn, J. M., Frei, B. L., Burgess, D. S., Talbert, R. L., Peters, J. I., Johnston, K. P., & Williams, R. O. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9904-6 · Cited by 65
Inhalable liposomal formulation for vasoactive intestinal peptide
Hajos, F., Stark, B., Hensler, S., Prassl, R., & Mosgoeller, W. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.01.046 · Cited by 64
Densmore, C. L., Giddings, T. H., Waldrep, J. C., Kinsey, B. M., & Knight, V. (1999) · The Journal of Gene Medicine · Cited by 62
Inhibition of Experimental Lung Metastasis by Aerosol Delivery of PEI–p53 Complexes
Gautam, A. K., Densmore, C. L., & Waldrep, J. C. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0138 · Cited by 61
Marier, J. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg317 · Cited by 61
Pitard, B., Oudrhiri, N., Lambert, O., Vivien, É., Masson, C., Wetzer, B., Hauchecorne, M., Scherman, D., Rigaud, J., Vigneron, J., et al. (2001) · The Journal of Gene Medicine · doi:10.1002/jgm.211 · Cited by 60
Ultra-Fast Absorption of Amorphous Pure Drug Aerosols via Deep Lung Inhalation
Rabinowitz, J. D., Lloyd, P. M., Munzar, P., Myers, D. J., Cross, S., Damani, R., Quintana, R. J., Spyker, D. A., Soni, P., & Cassella, J. V. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20694 · Cited by 59
Eliyahu, H., Joseph, A. Z., Schillemans, J. P., Azzam, T., Domb, A. J., & Barenholz, Y. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.09.001 · Cited by 59
Manford, F., Tronde, A., Jeppsson, A. ‐., Patel, N., Johansson, F., & Forbes, B. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.07.010 · Cited by 58
Cationic submicron emulsions for pulmonary DNA immunization
Bivas‐Benita, M., Oudshoorn, M., Romeijn, S. G., et al. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.08.008 · Cited by 57
In Vivo Gene Transfer to the Mouse Nasal Cavity Mucosa Using a Stable Cationic Lipid Emulsion
Kim, T. W., Chung, H., Kwon, I. C., et al. (2000) · Molecules and Cells · doi:10.1007/s10059-000-0142-1 · Cited by 51
Advances in Noninvasive Pulmonary Gene Therapy
Densmore, C. L. (2005) · Current Drug Delivery · doi:10.2174/156720106775197547 · Cited by 51
Development of Liposomal Amphotericin B Dry Powder Inhaler Formulation
Shah, S. P., & Misra, A. R. (2004) · Drug Delivery · doi:10.1080/10717540490467375 · Cited by 50
Lymphatic uptake of lipid nanoparticles following endotracheal administration
Videira, M., Gano, L., dos Santos, C. P., Neves, M., & Almeida, A. J. (2006) · Journal of Microencapsulation · doi:10.1080/02652040600788221 · Cited by 49
A new biocompatible nanoparticle delivery system for the release of fibrinolytic drugs
Piras, A. M., Chiellini, E., Fiumi, C., Bartoli, C., Chiellini, E., Fiorentino, B., & Farina, C. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.01.035 · Cited by 49
Park, M. R., Kim, H. W., Hwang, C. S., Han, K. O., Choi, Y. J., Song, S., Cho, M., & Cho, C. S. (2007) · The Journal of Gene Medicine · doi:10.1002/jgm.1139 · Cited by 46
Hwang, S.-K., Jin, H., Kwon, J. T., Chang, S.-H., Kim, T. H., Cho, C.-S., Lee, K. H., Young, M. R., Colburn, N. H., Beck, G. R., et al. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302983 · Cited by 44
Mansour, H. M., & Zografi, G. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20810 · Cited by 44
Self-citationStark, B., Debbage, P. L., Andreae, F., Mosgoeller, W., & Prassl, R. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.11.017 · Cited by 42
Galactose-poly(ethylene glycol)-polyethylenimine for improved lung gene transfer
Chen, J., Gao, X., Hu, K., Pang, Z., Cai, J., Li, J., Wu, H., & Jiang, X. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.08.006 · Cited by 42
Gibbons, A., McElvaney, N. G., Taggart, C. C., & Cryan, S. (2008) · Journal of Microencapsulation · doi:10.1080/02652040802466535 · Cited by 40
Depot formulation of vasoactive intestinal peptide by protamine-based biodegradable nanoparticles
Wernig, K., Griesbacher, M., Andreae, F., Hajos, F., Wagner, J., Mosgoeller, W., & Zimmer, A. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.06.005 · Cited by 40
Nonviral Delivery for Genomic Therapy of Cancer
Templeton, N. S. (2008) · World Journal of Surgery · doi:10.1007/s00268-008-9825-0 · Cited by 39
Steckel, H., & Müller, B. W. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00237-3 · Cited by 39
A preliminary pharmacokinetic study of liposomal leuprolide dry powder inhaler: A technical note
Shahiwala, A., & Misra, A. R. (2005) · AAPS PharmSciTech · doi:10.1208/pt060360 · Cited by 37
Pulmonary disposition of budesonide from liposomal dry prowder inhaler
Joshi, M., & Nisra, A. N. (2001) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2001.23.10.677118 · Cited by 36
Nano-Liposomal Dry Powder Inhaler of Amiloride Hydrochloride
Chougule, M. B., Padhi, B. K., & Misra, A. R. (2006) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2006.405 · Cited by 34
Ultrasonic Nebulization of Cationic Lipid-Based Gene Delivery Systems for Airway Administration
Pillai, R., Petrak, K., Blezinger, P., Deshpande, D., Florack, V. J., Freimark, B. D., Padmabandu, G., & Rolland, A. P. (1998) · Pharmaceutical Research · doi:10.1023/a:1011964813817 · Cited by 32
Hickey, A. J. (1993) · Aerosol Science and Technology · doi:10.1080/02786829308959606 · Cited by 32
Formulation Challenges of Powders for the Delivery of Small Molecular Weight Molecules as Aerosols
Hickey, A. J. (2002) · CRC Press eBooks · doi:10.1201/9780203910337-73 · Cited by 29
Disposition kinetics of ketotifen from liposomal dry powder for inhalation in rat lung
Joshi, M., & Misra, A. R. (2003) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2003.03813.x · Cited by 28
Gong, F., Tang, H., Lin, Y., Gu, W., Wang, W., & Kang, M.-L. (2005) · Pediatrics International · doi:10.1111/j.1442-200x.2005.02060.x · Cited by 26
Kaipel, M., Wagner, A., Wassermann, E., Vorauer‐Uhl, K., Kellner, R., Redl, H., Katinger, H. W. D., & Ullrich, R. (2008) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2007.0667 · Cited by 23
Formulation Challenges of Powders for the Delivery of Small Molecular Weight Molecules as Aerosols
Hickey, A. J., & Mansour, H. M. (2008) · CRC Press eBooks · doi:10.3109/9781420045260-44 · Cited by 22
Self-citationAvram, M. J., Henthorn, T. K., Spyker, D. A., et al. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.010652 · Cited by 21
El-Baseir, M. M., Phipps, M. A., & Kellaway, I. W. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(96)04873-9 · Cited by 18
Miguel, A. H., Eiguren-Fernandez, A., Sioutas, C., Fine, P. M., Geller, M. D., & Mayo, P. R. (2005) · Aerosol Science and Technology · doi:10.1080/027868290950338 · Cited by 17
de Semir, D., Pétriz, J., Aviñó, A. M., Larriba, S., Nunes, V., Casals, T., Estivill, X., & Aran, J. M. (2002) · The Journal of Gene Medicine · doi:10.1002/jgm.264 · Cited by 17
Cited by
Huh, A. J., & Kwon, Y. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.002 · Cited by 1,864
Imaging and drug delivery using theranostic nanoparticles
Janib, S. M., Moses, A. S., & MacKay, J. A. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.08.004 · Cited by 1,248
Targeted drug delivery strategies for precision medicines
Manzari, M. T., Shamay, Y., Kiguchi, H., Rosen, N., Scaltriti, M., & Heller, D. A. (2021) · Nature Reviews Materials · doi:10.1038/s41578-020-00269-6 · Cited by 1,183
Challenges in Development of Nanoparticle-Based Therapeutics
Desai, N. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9339-4 · Cited by 1,173
Toxicology and clinical potential of nanoparticles
Yildirimer, L., Thanh, N. T. K., Loizidou, M., & Seifalian, A. M. (2011) · Nano Today · doi:10.1016/j.nantod.2011.10.001 · Cited by 676
Metadata
- Authors
- Mansour, H., Haemosu, & Wu, X.
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2009-12
- Volume
- 4
- Pages
- 299
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- OpenAlex
- W2098205520
- Cited by
- 485
- References
- 180
- FWCI
- 18.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.